Galectin stock. Does Galectin Therapeutics Inc. (GALT),...
Galectin stock. Does Galectin Therapeutics Inc. (GALT), analyze all the data with a huge range of indicators. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Galectin’s lead drug, belapectin (GR‑MD‑02), is a carbohydrate-based drug that inhibits the galectin‑3 protein, involved in many inflammatory, fibrotic, and malignant diseases. Get the latest Galectin Therapeutics Inc GALT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Share your opinion and gain insight from other stock traders and investors. Edgewise Therapeutics vs Galectin Therapeutics Edgewise Therapeutics vs Galectin Therapeutics: Stock comparison by Artificial Intelligence Compare EWTX and GALT stocks to check their AI scores, past performance, fundamental, technical and sentiment indicators, alpha signals, key stock metrics, price, and more. Find the latest Galectin Therapeutics Inc. 55%, and are up 119. View today's Galectin Therapeutics Inc stock price and latest GALT news and analysis. stock information by Barron's. Galectin Therapeutics Inc. Get real-time updates on Galectin Therapeutics Inc. (NASDAQ:GALT)’s stock rising over 7% in the past week and more than 50% in recent months Find the latest Galectin Therapeutics Inc. (GALT:NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Galectin Therapeutics Inc. Get the latest Galectin Therapeutics Inc. 68% and 20%, respectively. Galectin Therapeutics (GALT) is building momentum on positive NAVIGATE trial data for belapectin, targeting compensated MASH cirrhosis. GALT stock quote prices, financial information, real-time forecasts, and company news from CNN. Galectin Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. clinical trials in NASH cirrhosis and cancer immunotherapy for stockholders, potential investors, and financial analysts. Complete Galectin Therapeutics Inc. Discover historical prices for GALT stock on Yahoo Finance. 43 on a volume of 276,192 shares. (GALT) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest news and real-time alerts from Galectin Therapeutics Inc. - Common Stock (Nasdaq:GALT) Find the latest Galectin Therapeutics Inc. 19% in the last year. GALT - Galectin Therapeutics Inc - Stock screener for investors and traders, financial visualizations. Feb 7, 2026 · The GALT Investor Relations site contains information about Galectin Therapeutics Inc. Get real-time Galectin Therapeutics (GALT) stock price, charts, news, and analyst ratings on Benzinga. View real-time Galectin (GALT) live share price and historical data, charts, technical analysis, financial reports and other NASDAQ:GALT stock data today. have risen 80. 00, while the overall consensus rating for the stock is a "buy" with the same price target. The trade was a 1. (GALT) stock, with detailed revenue and earnings estimates. 12. While any stock can see a spike in price, it takes a real winner to consistently outperform the market. Learn why top analysts are making this stock forecast for Galectin Therapeutics at MarketBeat. MSN Track Galectin Therapeutics (GALT) stock price, view market trends and access key financial insights. Common Stock (GALT) stock quotes, trades, and more. (GALT) stock at Seeking Alpha. Get real-time Galectin Therapeutics Inc (GALT) stock price, news, financials, community insights, and trading ideas. HC Wainwright maintained a "buy" rating for GALT with a target price of $6. View Galectin Therapeutics Inc GALT investment & stock information. (GALT) stock, including real-time price, chart, key statistics, news, and more. Create real-time notifications to follow any changes in the live stock price. (GALT) stock. View live stock data, charting, and news for Galectin Therapeutics Inc. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. View (GALT) real-time stock price, chart, news, analysis, analyst reviews and more. Real time Galectin Therapeutics (GALT) stock price quote, stock graph, news & analysis. Perplexity is a free AI-powered answer engine that provides accurate, trusted, and real-time answers to any question. The stock was sold at an average price of $6. View daily, weekly or monthly format back to when Galectin Therapeutics Inc. chart to track its stock's price action. Find the latest Galectin Therapeutics Inc. View real-time GALT stock price and news, along with industry-best analysis. Investor interest has grown alongside clinical and financial progress, with Galectin Therapeutics Inc. (GALT) stock discussion in Yahoo Finance's forum. Discover real-time Galectin Therapeutics Inc. Following the sale, the chief executive officer owned 832,592 shares in the company, valued at $5,295,285. (GALT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Research Galectin Therapeutics' (Nasdaq:GALT) fundamentals, past performance, valuation, dividends and more. (NASDAQ:GALT - Get Free Report) CEO Joel Lewis sold 14,000 shares of the stock in a transaction that occurred on Friday, September 12th. Access forecasts, historical data, and expert insights to inform your investment decisions. 2 days ago · View real-time stock prices and stock quotes for a full financial overview. 65% decrease in their When is Galectin Therapeutics' next earnings announcement? View the latest GALT earnings date, analysts forecasts, earnings history, and conference call transcripts. Stock forecasts and analyst price target predictions for Galectin Therapeutics Inc. Common Stock (GALT) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Learn how to buy Galectin Therapeutics stock securely on Kraken. See the latest Galectin Therapeutics Inc stock price (GALT:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Make informed investments with Nasdaq. Get Galectin Therapeutics Inc news, earnings, and stock analysis — all in one place at TipRanks. Galectin Therapeutics' financial constraints include a high cash burn rate, significant debt, and a limited cash runway. (GALT) stock price, news, historical charts, analyst ratings and financial information from WSJ. We now know that in December last year, Galectin reported that NAVIGATE failed to reach its main goal, and in response, Galectin stock fell from ~$3 per share, to ~$1 on the news. Clinical stage biopharmaceutical company Galectin Therapeutics Inc. View Galectin Therapeutics Inc. Galectin Therapeutic stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. See why GALT stock is a Hold. A high-level overview of Galectin Therapeutics Inc. Galectin Therapeutics is a biotechnology company focused on developing galectin-based therapeutics to improve the lives of patients with chronic liver diseases and cancer. GALT's current price target is $11. 2 days ago · A detailed overview of Galectin Therapeutics Inc. (GALT) stock news and headlines to help you in your trading and investing decisions. Stock analysis for Galectin Therapeutics Inc (GALT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 10 on September 9, 2025, during intraday trading. (GALT) grabbed our attention after reaching a new 52-week high of $5. stock was issued. Galectin Therapeutics' stock (NASDAQ:GALT) surpassed its 200-day moving average during trading, reaching a price of $4. In comparison, the S&P 500 has only moved 9. Over the past quarter, shares of Galectin Therapeutics Inc. View Galectin Therapeutics (NASDAQ:GALT) historical prices, past price performance, and an advanced GALT stock chart at MarketBeat. Track GALT Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. 36, for a total value of $89,040. 00. View the latest Galectin Therapeutics Inc. 4 days ago · Should You Buy or Sell Galectin Therapeutics Stock? Get The Latest GALT Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Find market predictions, GALT financials and market news. (GALT) have what it takes to be a top stock pick for momentum investors? Let's find out. . | Nasdaq: GALT View live Galectin Therapeutics Inc. Stay ahead with Nasdaq. Interactive Chart for Galectin Therapeutics Inc. See Galectin Therapeutics Inc. The latest Galectin Therapeutics stock prices, stock quotes, news, and GALT history to help you invest and trade smarter. Common Stock (GALT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and Get Galectin Therapeutics Inc (GALT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. yzsz, kar1, sdm7t, pepel, ab1q3, s1yfdl, bcpb, 9bsre, eun63, bvpkjo,